154 related articles for article (PubMed ID: 232665)
1. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
Irons LI; MacLennan AP
Biochim Biophys Acta; 1979 Sep; 580(1):175-85. PubMed ID: 232665
[TBL] [Abstract][Full Text] [Related]
2. Separation and purification of the hemagglutinins from Bordetella pertussis.
Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
[TBL] [Abstract][Full Text] [Related]
3. Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography.
Ozcengiz E; Kilinç K; Büyüktanir O; Günalp A
Vaccine; 2004 Mar; 22(11-12):1570-5. PubMed ID: 15063583
[TBL] [Abstract][Full Text] [Related]
4. Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.
Skelton SK; Wong KH
J Clin Microbiol; 1990 May; 28(5):1062-5. PubMed ID: 2351723
[TBL] [Abstract][Full Text] [Related]
5. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
Askelöf P; Gillenius P
Infect Immun; 1982 Jun; 36(3):958-61. PubMed ID: 6284647
[TBL] [Abstract][Full Text] [Related]
6. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
Robinson A; Hawkins DC
Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay.
Askelöf P; Granström M; Gillenius P; Lindberg AA
J Med Microbiol; 1982 Feb; 15(1):73-83. PubMed ID: 6292428
[TBL] [Abstract][Full Text] [Related]
8. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.
Ashworth LA; Fitzgeorge RB; Irons LI; Morgan CP; Robinson A
J Hyg (Lond); 1982 Jun; 88(3):475-86. PubMed ID: 6282959
[TBL] [Abstract][Full Text] [Related]
9. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
Morse SI; Morse JH
J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
[TBL] [Abstract][Full Text] [Related]
10. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography.
Chong P; Klein M
Biochem Cell Biol; 1989 Jul; 67(7):387-91. PubMed ID: 2477043
[TBL] [Abstract][Full Text] [Related]
11. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis.
Arai H; Munoz JJ
Infect Immun; 1979 Jul; 25(1):460-2. PubMed ID: 39033
[TBL] [Abstract][Full Text] [Related]
12. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
13. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
Semina IE; Iankina ZK
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of pertussigen from Bordetella pertussis.
Arai H; Munoz JJ
Infect Immun; 1981 Jan; 31(1):495-9. PubMed ID: 6260667
[TBL] [Abstract][Full Text] [Related]
15. Bacterial growth and virulence factors production by different Bordetella pertussis strains.
Letowska I; Chodorowska M; Kaczurba E; Kuklińska D; Tyski S
Acta Microbiol Pol; 1997; 46(1):45-55. PubMed ID: 9271847
[TBL] [Abstract][Full Text] [Related]
16. [The phenotypic properties of freshly isolated strains of Bordetella].
Lapaeva IA; Milanko AIa; Mebel' SM; Siniashina LN; Ferkel' GIa; Khramova NN; Tepliakova AI; Lomonosova GG; Volgina TI; Shumakov IuL
Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):13-6. PubMed ID: 1678567
[TBL] [Abstract][Full Text] [Related]
17. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities.
Utsumi S; Sonoda S; Imagawa T; Kanoh M
Biken J; 1978 Dec; 21(4):121-35. PubMed ID: 224858
[TBL] [Abstract][Full Text] [Related]
18. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
Selmer JC; Larsen FS; Hertz JB; Parton R
Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytosis-promoting factor produced by Bordetella pertussis. Partial purification and characterization.
Uiwasa S; Ishida S; Asakawa S; Kurokawa M
Jpn J Med Sci Biol; 1968 Oct; 21(5):363-8. PubMed ID: 4304392
[No Abstract] [Full Text] [Related]
20. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
Redhead K; Seagroatt V
J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
